Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann Gils

Showing results (1-10 of 162) with videos related to

Pageof 17
Sort By:
Digestive Diseases (Basel, Switzerland)|February 2, 2017
Combining Therapeutic Drug Monitoring with Biosimilars, a Strategy to Improve the Efficacy of Biologicals for Treating Inflammatory Bowel Diseases at an Affordable CostAnn Gils
Therapeutic Drug Monitoring|March 19, 2019
Pharmacodynamic Monitoring of Biological Therapies in Chronic Inflammatory DiseasesErwin Dreesen, Ann Gils
Journal of Crohn'S & Colitis|March 24, 2017
Blocking α4β7 Integrin Through Vedolizumab: Necessary but not Sufficient?Erwin Dreesen, Ann Gils
Current Pharmaceutical Design|December 1, 2017
Risk Assessment and Monitoring of Antibody Responses to Biosimilars in Chronic Inflammatory DiseasesIris Detrez, Ann Gils
Journal of Crohn'S & Colitis|August 3, 2016
Pharmacokinetics and Exposure-response Relationship of Golimumab in Patients with Moderately-to-severely Active Ulcerative Colitis: Results from Phase 2/3 PURSUIT Induction and Maintenance StudiesIris Detrez, Ann Gils
Alimentary Pharmacology & Therapeutics|October 16, 2018
Letter: overcoming secondary loss of response to infliximab-it is not the drug, it is how you use it! Authors' replyErwin Dreesen, Ann Gils
Thrombosis Research|July 31, 2012
Is there any need for a TAFI(a) inhibitor as thrombolytic drug?Ellen Vercauteren, Ann Gils
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 30, 2019
ReplyErwin Dreesen, Ann Gils
Frontline Gastroenterology|January 8, 2013
Value of drug level testing and antibody assays in optimising biological therapySéverine Vermeire, Ann Gils
Current Medicinal Chemistry|September 24, 2004
Plasminogen activator inhibitor-1Ann Gils, Paul J Declerck
Pageof 17

Showing results (1-10 of 162) with videos related to

Sort By:
Pageof 17
Digestive Diseases (Basel, Switzerland)|February 2, 2017
Combining Therapeutic Drug Monitoring with Biosimilars, a Strategy to Improve the Efficacy of Biologicals for Treating Inflammatory Bowel Diseases at an Affordable CostAnn Gils
Therapeutic Drug Monitoring|March 19, 2019
Pharmacodynamic Monitoring of Biological Therapies in Chronic Inflammatory DiseasesErwin Dreesen, Ann Gils
Journal of Crohn'S & Colitis|March 24, 2017
Blocking α4β7 Integrin Through Vedolizumab: Necessary but not Sufficient?Erwin Dreesen, Ann Gils
Current Pharmaceutical Design|December 1, 2017
Risk Assessment and Monitoring of Antibody Responses to Biosimilars in Chronic Inflammatory DiseasesIris Detrez, Ann Gils
Journal of Crohn'S & Colitis|August 3, 2016
Pharmacokinetics and Exposure-response Relationship of Golimumab in Patients with Moderately-to-severely Active Ulcerative Colitis: Results from Phase 2/3 PURSUIT Induction and Maintenance StudiesIris Detrez, Ann Gils
Alimentary Pharmacology & Therapeutics|October 16, 2018
Letter: overcoming secondary loss of response to infliximab-it is not the drug, it is how you use it! Authors' replyErwin Dreesen, Ann Gils
Thrombosis Research|July 31, 2012
Is there any need for a TAFI(a) inhibitor as thrombolytic drug?Ellen Vercauteren, Ann Gils
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 30, 2019
ReplyErwin Dreesen, Ann Gils
Frontline Gastroenterology|January 8, 2013
Value of drug level testing and antibody assays in optimising biological therapySéverine Vermeire, Ann Gils
Current Medicinal Chemistry|September 24, 2004
Plasminogen activator inhibitor-1Ann Gils, Paul J Declerck
Pageof 17